Hikma Pharmaceuticals PLC (HIK.L)

GBp 2006.0

(0.35%)

EBITDA Summary of Hikma Pharmaceuticals PLC

  • Hikma Pharmaceuticals PLC's latest annual EBITDA in 2023 was 791 Million USD , up 14.15% from previous year.
  • Hikma Pharmaceuticals PLC's latest quarterly EBITDA in 2024 Q2 was 499 Million USD , down 0.0% from previous quarter.
  • Hikma Pharmaceuticals PLC reported an annual EBITDA of 485 Million USD in 2022, down -3.54% from previous year.
  • Hikma Pharmaceuticals PLC reported an annual EBITDA of 744 Million USD in 2021, up 20.95% from previous year.
  • Hikma Pharmaceuticals PLC reported a quarterly EBITDA of 345 Million USD for 2023 Q4, down 0.0% from previous quarter.
  • Hikma Pharmaceuticals PLC reported a quarterly EBITDA of 446 Million USD for 2023 Q2, down 0.0% from previous quarter.

Annual EBITDA Chart of Hikma Pharmaceuticals PLC (2023 - 2002)

Historical Annual EBITDA of Hikma Pharmaceuticals PLC (2023 - 2002)

Year EBITDA EBITDA Growth
2023 791 Million USD 14.15%
2022 485 Million USD -3.54%
2021 744 Million USD 20.95%
2020 654 Million USD 11.99%
2019 584 Million USD 10.82%
2018 527 Million USD 14.32%
2017 554 Million USD -8.89%
2016 506 Million USD 10.24%
2015 459 Million USD -4.57%
2014 481 Million USD 5.25%
2013 457 Million USD 102.08%
2012 226.14 Million USD 37.73%
2011 154.64 Million USD -5.36%
2010 173.48 Million USD 22.96%
2009 141.09 Million USD 23.92%
2008 113.86 Million USD -3.39%
2007 117.85 Million USD 24.84%
2006 94.35 Million USD 15.4%
2005 79.69 Million USD 16.85%
2004 68.63 Million USD 102.31%
2003 34.63 Million USD 20.52%
2002 28.71 Million USD 0.0%

Peer EBITDA Comparison of Hikma Pharmaceuticals PLC

Name EBITDA EBITDA Difference